Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Cusi

Showing results (101-110 of 189) with videos related to

Pageof 19
Sort By:
The Journal of Clinical Endocrinology and Metabolism|April 18, 2015
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase LevelsPaola Portillo-Sanchez, Fernando Bril, Maryann Maximos, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 11, 2017
Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 DiabetesFernando Bril, Srilaxmi Kalavalapalli, Virginia C Clark, et al.
Journal of Hepatology|September 9, 2014
Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitisFernando Bril, Maryann Maximos, Paola Portillo-Sanchez, et al.
The New England Journal of Medicine|November 13, 2020
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic SteatohepatitisPhilip N Newsome, Kristine Buchholtz, Kenneth Cusi, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 9, 2010
Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trialsPeter H Jones, Kenneth Cusi, Michael H Davidson, et al.
Plos One|July 19, 2019
Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosisJohann Colomba, Silvia R Netedu, Catherine Lehoux-Dubois, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|January 13, 2016
Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetesFernando Bril, Sushma Kadiyala, Paola Portillo Sanchez, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 6, 2004
Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetesSangeeta R Kashyap, Renata Belfort, Rachele Berria, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 8, 2015
Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patientsFernando Bril, Carolina Ortiz-Lopez, Romina Lomonaco, et al.
Diabetes Care|February 11, 2016
Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 DiabetesRomina Lomonaco, Fernando Bril, Paola Portillo-Sanchez, et al.
Pageof 19

Showing results (101-110 of 189) with videos related to

Sort By:
Pageof 19
The Journal of Clinical Endocrinology and Metabolism|April 18, 2015
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase LevelsPaola Portillo-Sanchez, Fernando Bril, Maryann Maximos, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 11, 2017
Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 DiabetesFernando Bril, Srilaxmi Kalavalapalli, Virginia C Clark, et al.
Journal of Hepatology|September 9, 2014
Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitisFernando Bril, Maryann Maximos, Paola Portillo-Sanchez, et al.
The New England Journal of Medicine|November 13, 2020
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic SteatohepatitisPhilip N Newsome, Kristine Buchholtz, Kenneth Cusi, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 9, 2010
Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trialsPeter H Jones, Kenneth Cusi, Michael H Davidson, et al.
Plos One|July 19, 2019
Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosisJohann Colomba, Silvia R Netedu, Catherine Lehoux-Dubois, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|January 13, 2016
Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetesFernando Bril, Sushma Kadiyala, Paola Portillo Sanchez, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 6, 2004
Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetesSangeeta R Kashyap, Renata Belfort, Rachele Berria, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 8, 2015
Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patientsFernando Bril, Carolina Ortiz-Lopez, Romina Lomonaco, et al.
Diabetes Care|February 11, 2016
Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 DiabetesRomina Lomonaco, Fernando Bril, Paola Portillo-Sanchez, et al.
Pageof 19